Literature DB >> 31930297

Treatment of Latent Tuberculosis Infection Based on the Interferon-γ Release Assay in Allogeneic Stem Cell Transplant Recipients.

Joung Ha Park1, Eun-Ji Choi2, Han-Seung Park2, Sang-Ho Choi1, Sang-Oh Lee1, Yang Soo Kim1, Jun Hee Woo1, Jung-Hee Lee2, Je-Hwan Lee2, Kyoo-Hyung Lee2, Tae Sun Shim3, Sung-Han Kim1.   

Abstract

In hematopoietic stem cell transplant recipients, the incidence of tuberculosis in positive interferon-γ release assay (IGRA) without isoniazid prophylaxis (3.58/100 person-years) was higher than in negative or indeterminate IGRA (1.15/100 person-years; P = .01) and in positive IGRA with isoniazid prophylaxis (0/100 person-years; P = .09). The number needed to treat was 22 (95% confidence interval, 12-99) with positive IGRA results.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  hematopoietic stem cell transplant; interferon-γ release assay; latent tuberculosis

Year:  2020        PMID: 31930297     DOI: 10.1093/cid/ciaa030

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

1.  Identification and Treatment of Tuberculosis in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Review of the Literature.

Authors:  Xiaodong Wang; Uet Yu; Xiaonan Li; Chunjing Wang; Qian Zhang; Chunlan Yang; Xiaoling Zhang; Yu Zhang; Ying Wang; Yuejie Zheng; Jikui Deng; Weiguo Yang; Guosheng Liu; Guofang Deng; Sixi Liu; Feiqiu Wen
Journal:  Infect Drug Resist       Date:  2020-07-31       Impact factor: 4.003

2.  Disseminated Tuberculosis with Cholecystitis in a Patient after Cord Blood Transplantation.

Authors:  Takaaki Konuma; Masamichi Isobe; Eisuke Adachi; Seiko Kato; Satoshi Takahashi; Hiroshi Yotsuyanagi; Arinobu Tojo
Journal:  Intern Med       Date:  2020-07-14       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.